<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One of the hallmarks of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Elucidating the mechanisms of how <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells evade or delay <z:mpath ids='MPATH_3'>apoptosis</z:mpath> should lead to novel therapeutic strategies </plain></SENT>
<SENT sid="2" pm="."><plain>Previously, we showed that HT-29 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells undergoing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> overexpressed cyclooxygenase-2 (COX-2), in a p38 dependent pathway, to delay <z:chebi fb="0" ids="9908">ursolic acid</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we focused on elucidating the upstream signaling pathways regulating this resistance mechanism </plain></SENT>
<SENT sid="4" pm="."><plain>The role of ATP as an extracellular signaling molecule took a long time to be accepted </plain></SENT>
<SENT sid="5" pm="."><plain>In recent years, ATP and its analogs, via the activation of specific purinergic receptors, have been implicated in many biological processes including cell proliferation, differentiation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>In the present report, we have demonstrated a novel role involving purinergic receptors and particularly the P2Y(2) receptor in resistance to <z:chebi fb="0" ids="9908">ursolic acid</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both colorectal HT-29 and prostate DU145 <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>We found that <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> induced an increase in intracellular ATP and P2Y(2) transcript levels </plain></SENT>
<SENT sid="8" pm="."><plain>Upon activation, P2Y(2) activated Src which in turn phosphorylated p38 leading to COX-2 overexpression which induced resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both HT-29 and DU145 cells </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, Ca(2+)-independent <z:chebi fb="79" ids="53407">PLA</z:chebi>(2) (iPLA(2)) and Ca(2+)-dependent secretory <z:chebi fb="79" ids="53407">PLA</z:chebi>(2) (sPLA(2)) were responsible for <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> release, the substrate of COX-2 </plain></SENT>
<SENT sid="10" pm="."><plain>Our findings document that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> triggering was dependent on protein kinase C (PKC) activation in both cell lines after <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> treatment </plain></SENT>
</text></document>